Carisma Therapeutics Inc. Shareholders' Equity
Carisma Therapeutics Inc. had Shareholders' Equity of $26.53 million as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-04-01
- 2023-12-31: Stockholders' Equity Attributable to Parent $26.53M.
- 2023-09-30: Stockholders' Equity Attributable to Parent $46.30M.
- 2023-06-30: Stockholders' Equity Attributable to Parent $66.70M.
- 2023-03-31: Stockholders' Equity Attributable to Parent $86.07M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2023-12-31 | $26.53M 10-K · filed 2024-04-01 | |
| 2023-09-30 | $46.30M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $66.70M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $86.07M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$157.06M 10-K · filed 2024-04-01 | $158.19M 10-K · filed 2023-02-28 |
| 2022-09-30 | $165.03M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $142.36M 10-Q · filed 2022-11-07 | |
| 2022-03-31 | $172.80M 10-Q · filed 2022-11-07 | |
| 2021-12-31 | $171.71M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $161.01M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $49.35M 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $9.27M 10-Q · filed 2022-11-07 | |
| 2020-12-31 | -$9.23M 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$16.55M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | -$2.63M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $18.45M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | -$26.70M 10-K · filed 2023-02-28 | |
| 2019-09-30 | $2.47M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $15.37M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $38.06M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $44.21M 10-K · filed 2022-02-28 | |
| 2018-09-30 | $50.40M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $64.06M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $23.86M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $18.03M 10-K · filed 2021-03-15 | |
| 2017-09-30 | $17.07M 10-Q · filed 2017-11-17 | |
| 2017-06-30 | $25.91M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $32.91M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $38.68M 10-K · filed 2020-03-16 | |
| 2016-09-30 | $41.45M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $6.17M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $11.97M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $18.94M 10-K · filed 2019-03-01 | |
| 2015-09-30 | $28.66M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $37.22M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $30.97M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $36.83M 10-K · filed 2018-04-02 | |
| 2014-09-30 | $28.78M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $38.62M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $46.23M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$54.33M 10-K · filed 2017-03-24 | |
| 2012-12-31 | -$39.30M 10-K · filed 2016-03-25 | |
| 2011-12-31 | -$19.79M 10-K · filed 2015-03-06 |